MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, SNDX has $551,792K in assets. $436,362K in debts. $116,808K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
464.00%
Quick Ratio
442.11%
Cash Ratio
102.30%
Debt to Asset Ratio
79.08%
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Royalty interest financing liabi...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
116,808 108,636
Short-term investments
319,171 346,597
Accounts receivable, net
25,403 19,454
Inventory
25,000 17,696
Short-term deposits
18,195 13,473
Other receivable, net
0 3,629
Collaboration receivable, net
15,736 12,316
Prepaid expenses and other current assets
9,517 9,875
Total current assets
529,830 531,676
Long-term investments
20,146 62,627
Property and equipment, net
128 0
Right-of-use asset, net
1,471 1,629
Restricted cash
217 217
Total assets
551,792 596,149
Accounts payable
13,826 17,353
Collaboration payable, net
0 0
Royalty payable
-4,783
Accrued expenses and other current liabilities
77,105 71,066
Current portion of royalty interest financing liability
22,925 19,435
Current portion of right-of-use liability
329 344
Current portion of capital lease
2 6
Total current liabilities
114,187 112,987
Royalty interest financing liability, less current portion
320,985 324,413
Right-of-use liability, less current portion
1,190 1,325
Total long-term liabilities
322,175 325,738
Total liabilities
436,362 438,725
Common stock, 0.0001 par value, 200,000,000 shares authorized 86,905,343 and 85,694,443 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively
9 9
Additional paid-in capital
1,553,462 1,534,981
Accumulated other comprehensive gain
525 285
Accumulated deficit
-1,438,566 -1,377,851
Total stockholders equity
115,430 157,424
Total liabilities and stockholders equity
551,792 596,149
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$9,517K Collaboration receivable, net$15,736K Short-term deposits$18,195K Inventory$25,000K Accounts receivable, net$25,403K Short-term investments$319,171K Cash and cashequivalents$116,808K Restricted cash$217K Right-of-use asset, net$1,471K Property and equipment,net$128K Long-term investments$20,146K Total current assets$529,830K Total assets$551,792K Total liabilities andstockholders equity$551,792K Total stockholdersequity$115,430K Total liabilities$436,362K Accumulated deficit-$1,438,566K Accumulated othercomprehensive gain$525K Additional paid-in capital$1,553,462K Total long-termliabilities$322,175K Total currentliabilities$114,187K Common stock, 0.0001par value,...$9K Right-of-use liability, lesscurrent portion$1,190K Royalty interestfinancing liability, less...$320,985K Current portion ofcapital lease$2K Current portion ofright-of-use liability$329K Current portion ofroyalty interest...$22,925K Accrued expenses andother current...$77,105K Accounts payable$13,826K

Syndax Pharmaceuticals Inc (SNDX)

Syndax Pharmaceuticals Inc (SNDX)